Forbes Breaking News
@ForbesBreakingNews·5.5M subscribers·180.5K videos
Novo Nordisk Sues GLP-1 Rival Eli Lilly For Misleading Advertising
Posted
July 21, 2026
Views
567
Likes
7
Engagement
1.23%
July 21, 2026
567
7
1.23%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
3:51Now PlayingOzempic drugmaker Novo Nordisk sued rival GLP-1 manufacturer Eli Lilly in federal court Tuesday, accusing the company of using “intentionally selected outdated studies” to curate allegedly misleading ad campaigns that exaggerate the efficacy of Lilly’s products.
Stay Connected
Forbes Breaking News on X
Forbes Breaking News on TikTok
More From Forbes
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
